Loading...
Preclinical Development of an AAV8-hUGT1A1 Vector for the Treatment of Crigler-Najjar Syndrome
Adeno-associated viruses (AAVs) are among the most efficient vectors for liver gene therapy. Results obtained in the first hemophilia clinical trials demonstrated the long-term efficacy of this approach in humans, showing efficient targeting of hepatocytes with both self-complementary (sc) and singl...
Saved in:
| Published in: | Mol Ther Methods Clin Dev |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
American Society of Gene & Cell Therapy
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6348934/ https://ncbi.nlm.nih.gov/pubmed/30705921 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtm.2018.12.011 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|